DelveInsight’s, “Erosive Esophagitis Pipeline Insight, 2025,” report provides comprehensive insights about 3+ companies and 3+ pipeline drugs in Erosive Esophagitis pipeline landscape. It covers the ...

While oral medications are generally considered safer and more convenient than injections or inhalations, sometimes a simple ...

The treatment, Dupixent, was approved to treat eosinophilic esophagitis in adults and pediatric patients 12 and older weighing at least 88 pounds. Marc Rothenberg, MD, PhD, director of the Cincinnati ...

Every year, people around the world take an astonishing 3.8 trillion doses of medicine. Most of these medicines are swallowed ...

SILVER SPRING, Md., May 20, 2022 /PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Dupixent (dupilumab) to treat eosinophilic esophagitis (EoE) in adults and pediatric patients 12 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Allergens trigger the release of IL-18, which produces ...

Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on developing and commercializing novel treatments for gastrointestinal (GI) diseases, today announced the first ...

The Food and Drug Administration approved Dupixent as treatment for eosinophilic esophagitis in adults and children over the age of 12. In its announcement Friday afternoon, the FDA approved a 300 mg ...

The FDA accepted Takeda’s new drug application for TAK-721, its eosinophilic esophagitis treatment, the company announced Dec. 15. The FDA also granted the treatment priority review. If approved, the ...

Pain in the chest when swallowing can be the result of consuming something too hot or too big. But it can also be a sign of an underlying condition, such as esophagitis, a hiatal hernia, or cancer. A ...